CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
Chosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cutoff value for diagnostic validity of CYFRA 21-1 by Lumipulse® technology in patients with s...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN ES |
| Publicado: |
De Gruyter
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/982c08d81cda467fa39bf2018dbdc8d1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:982c08d81cda467fa39bf2018dbdc8d1 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:982c08d81cda467fa39bf2018dbdc8d12021-12-05T14:10:38ZCYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value2628-491X10.1515/almed-2020-0005https://doaj.org/article/982c08d81cda467fa39bf2018dbdc8d12020-10-01T00:00:00Zhttps://doi.org/10.1515/almed-2020-0005https://doaj.org/toc/2628-491XChosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cutoff value for diagnostic validity of CYFRA 21-1 by Lumipulse® technology in patients with suspected cancer and also to determine if CYFRA 21-1 levels provide prognostic value.Garcia-Valdecasas Gayo SonsolesRuiz-Alvarez Maria JesusGonzalez-Gay DanielRamos-Corral RaquelMarquez-Lietor EvaDel Amo NazaretPlata Maria del CarmenGuillén-Santos RaquelArribas IgnacioCava-Valenciano FernandoDe Gruyterarticlebladder cancercutoffcyfra 21-1lung cancernon-small cell lung cancer (nsclc)prognosistumor markerMedical technologyR855-855.5ENESAdvances in Laboratory Medicine, Vol 1, Iss 4, Pp 160-5 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN ES |
| topic |
bladder cancer cutoff cyfra 21-1 lung cancer non-small cell lung cancer (nsclc) prognosis tumor marker Medical technology R855-855.5 |
| spellingShingle |
bladder cancer cutoff cyfra 21-1 lung cancer non-small cell lung cancer (nsclc) prognosis tumor marker Medical technology R855-855.5 Garcia-Valdecasas Gayo Sonsoles Ruiz-Alvarez Maria Jesus Gonzalez-Gay Daniel Ramos-Corral Raquel Marquez-Lietor Eva Del Amo Nazaret Plata Maria del Carmen Guillén-Santos Raquel Arribas Ignacio Cava-Valenciano Fernando CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value |
| description |
Chosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cutoff value for diagnostic validity of CYFRA 21-1 by Lumipulse® technology in patients with suspected cancer and also to determine if CYFRA 21-1 levels provide prognostic value. |
| format |
article |
| author |
Garcia-Valdecasas Gayo Sonsoles Ruiz-Alvarez Maria Jesus Gonzalez-Gay Daniel Ramos-Corral Raquel Marquez-Lietor Eva Del Amo Nazaret Plata Maria del Carmen Guillén-Santos Raquel Arribas Ignacio Cava-Valenciano Fernando |
| author_facet |
Garcia-Valdecasas Gayo Sonsoles Ruiz-Alvarez Maria Jesus Gonzalez-Gay Daniel Ramos-Corral Raquel Marquez-Lietor Eva Del Amo Nazaret Plata Maria del Carmen Guillén-Santos Raquel Arribas Ignacio Cava-Valenciano Fernando |
| author_sort |
Garcia-Valdecasas Gayo Sonsoles |
| title |
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value |
| title_short |
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value |
| title_full |
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value |
| title_fullStr |
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value |
| title_full_unstemmed |
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value |
| title_sort |
cyfra 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value |
| publisher |
De Gruyter |
| publishDate |
2020 |
| url |
https://doaj.org/article/982c08d81cda467fa39bf2018dbdc8d1 |
| work_keys_str_mv |
AT garciavaldecasasgayosonsoles cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue AT ruizalvarezmariajesus cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue AT gonzalezgaydaniel cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue AT ramoscorralraquel cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue AT marquezlietoreva cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue AT delamonazaret cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue AT platamariadelcarmen cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue AT guillensantosraquel cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue AT arribasignacio cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue AT cavavalencianofernando cyfra211inpatientswithsuspectedcancerevaluationofanoptimalcutofftoassessthediagnosticefficacyandprognosticvalue |
| _version_ |
1718371852630360064 |